Teresa Evans

Researcher

University of Arkansas for Medical Sciences

faculty

10 h-index 27 pubs 451 cited

Research Areas

Cervical Cancer and HPV Research Cancer Immunotherapy and Biomarkers Immune Response and Inflammation Head and Neck Cancer Studies T-cell and B-cell Immunology Health Sciences Research and Education

Links

Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Teresa Evans' research focuses on the development and evaluation of therapeutic vaccines for human papillomavirus (HPV) related conditions. Her work has investigated the use of PepCan, a peptide-based HPV therapeutic vaccine, in treating cervical intraepithelial neoplasia (CIN2/3). Studies have examined the immune responses generated by PepCan, both alone and in combination with adjuvants like Candida, and have assessed its efficacy in clinical trials. More recently, her research has extended to evaluating PepCan for reducing the recurrence of head and neck cancer. Evans has published 27 papers, accumulating 451 citations, and holds an h-index of 10. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Yong‐Chen Lu, Mayumi Nakagawa, Hannah Coleman, and Takeo Shibata, with whom she shares four co-authored publications.

Metrics

  • h-index: 10
  • Publications: 27
  • Citations: 451

Selected Publications

  • A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026) DOI
  • A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
  • Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus <i>Candida</i> adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024) DOI
  • A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
  • Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed (2021) DOI

Collaborators

Researchers in the database who share publications

Yong‐Chen Lu University of Arkansas for Medical Sciences 4 shared publications Mayumi Nakagawa University of Arkansas for Medical Sciences 4 shared publications Hannah Coleman University of Arkansas for Medical Sciences 4 shared publications Takeo Shibata University of Arkansas for Medical Sciences 4 shared publications David W. Ussery University of Arkansas for Medical Sciences 4 shared publications Jasmine Crane University of Arkansas for Medical Sciences 4 shared publications Nadia Darwish University of Arkansas for Medical Sciences 4 shared publications Charles M. Quick University of Arkansas for Medical Sciences 3 shared publications

Similar Researchers

Based on overlapping research topics

Hannah Coleman University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research Cancer Immunotherapy and Biomarkers Immune Response and Inflammation
Good match 4 shared topics
Benjamin J. Lieblong University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research Immune Response and Inflammation T-cell and B-cell Immunology
Good match 3 shared topics
Fariba Jousheghany University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers Immune Response and Inflammation T-cell and B-cell Immunology
Good match 3 shared topics
Jennifer L. Faulkner University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research Cancer Immunotherapy and Biomarkers Head and Neck Cancer Studies
Good match 3 shared topics
Michael Scott Robeson University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research Cancer Immunotherapy and Biomarkers Immune Response and Inflammation
Good match 3 shared topics
Mayumi Nakagawa University of Arkansas for Medical Sciences
Cervical Cancer and HPV Research Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology
Good match 3 shared topics